St Jude warns that batteries in up to 350K heart devices could fail startribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from startribune.com Daily Mail and Mail on Sunday newspapers.
Company Announcement
Boston Scientific Corporation (NYSE: BSX) has announced it has initiated a global, voluntary recall of all unused inventory of the LOTUS Edge™ Aortic Valve System due to complexities associated with the product delivery system. The voluntary recall is related solely to the delivery system, as the valve continues to achieve positive and clinically effective performance post-implant. There is no safety issue for patients who currently have an implanted LOTUS Edge valve.
Given the additional time and investment required to develop and reintroduce an enhanced delivery system, the company has chosen to retire the entire LOTUS product platform immediately. All related commercial, clinical, research & development and manufacturing activities will also cease.
Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation s Patent Infringement Case In California
News provided by
Share this article
Share this article
MARLBOROUGH, Mass., Dec. 14, 2020 /PRNewswire/ Boston Scientific Corporation (NYSE: BSX) today announced that a stipulation of dismissal has been filed in the Nevro Corporation (NYSE: NVRO) patent infringement case against Boston Scientific in the United States District Court for the Northern District of California. Nevro sought preliminary and permanent injunctive relief against further infringement as well as damages and attorney s fees. The case has now ended, with Nevro receiving none of its requested relief. There was no ruling which would impose any restrictions on any current or future Boston Scientific product. The official dismissal of the case is subject to the approval of the Court.